Which has grown faster, ASTH or NTLA?

Over the past five years, ASTH grew revenue faster — ASTH at a 53.77% CAGR versus NTLA at 7.31%.

Is ASTH or NTLA more profitable?

ASTH runs the higher net margin — ASTH at 1.05% versus NTLA at -672.16%.

How have ASTH and NTLA total returns compared?

Over the past 10 years, ASTH delivered 25.17% and NTLA delivered -3.03% annualized total return. Past performance doesn't predict future results.

Astrana Health, Inc. (ASTH) vs Intellia Therapeutics, Inc. (NTLA)

A side-by-side comparison of Astrana Health, Inc. and Intellia Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ASTH

Astrana Health, Inc.

$1.85B

$37.29HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

NTLA

Intellia Therapeutics, Inc.

$1.81B

$12.92HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT

Total return — ASTH vs NTLA

growth of $100 · dividends reinvested · last 10y

ASTH +824.9% (+24.9%/yr)NTLA -26.5% (-3.0%/yr)ASTH compounded faster over this window

Log scale — wide-divergence pair

ASTH NTLA

ASTH vs NTLA: by the numbers

•ASTH is the larger company ($1.85B vs $1.81B market cap).
•ASTH is profitable (1.05% net margin) while NTLA runs a net loss (-672.16%).
•ASTH grew revenue faster over the past five years (53.77% vs 7.31% CAGR).

Metrics side by side

Valuation

Metric	ASTH	NTLA
P/E ratio	45.61	N/A
Forward P/E	26.68	N/A
P/S ratio	0.48	30.34
P/B ratio	2.23	2.48
EV / EBITDA	13.57	N/A
FCF yield	8.57%	N/A

Profitability

Metric	ASTH	NTLA
Gross margin	9.22%	76.47%
Operating margin	2.61%	-651.67%
Net margin	1.05%	-672.16%
ROE	4.88%	-54.96%
ROIC	4.13%	-54.45%

Growth (annualized)

Metric	ASTH	NTLA
Revenue CAGR (5Y)	53.77%	7.31%
EPS CAGR (5Y)	-15.06%	N/A
FCF CAGR (5Y)	18.35%	N/A
Total return CAGR (5Y)	-16.52%	-37.13%

Frequently asked

Which has grown faster, ASTH or NTLA?: Over the past five years, ASTH grew revenue faster — ASTH at a 53.77% CAGR versus NTLA at 7.31%.
Is ASTH or NTLA more profitable?: ASTH runs the higher net margin — ASTH at 1.05% versus NTLA at -672.16%.
How have ASTH and NTLA total returns compared?: Over the past 10 years, ASTH delivered 25.17% and NTLA delivered -3.03% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ASTH analysis Full NTLA analysis Interactive comparison tool

Dig into the metrics

Astrana Health P/E ratio Astrana Health ROE Intellia Therapeutics ROE Astrana Health operating margin Intellia Therapeutics operating margin Astrana Health revenue growth Intellia Therapeutics revenue growth Astrana Health free cash flow Intellia Therapeutics free cash flow

Astrana Health & Intellia Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.